AG0301-COVID19

· AnGes, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AG0301-COVID19, covering 2021-08-18 to 2021-08-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of COVID-19 DNA Vaccine (AG0301-COVID19) [Phase 1, Phase 2]